Search by Drug Name or NDC
NDC 49483-0720-20 Maximum Strength Acid Reducer 20 mg/1 Details
Maximum Strength Acid Reducer 20 mg/1
Maximum Strength Acid Reducer is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TIME CAP LABORATORIES,INC. The primary component is FAMOTIDINE.
MedlinePlus Drug Summary
Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube that connects the mouth and stomach]); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas or small intestine that cause increased production of stomach acid). Over-the-counter famotidine is used to prevent and treat heartburn due to acid indigestion and sour stomach caused by eating or drinking certain foods or drinks. Famotidine is in a class of medications called H2 blockers. It works by decreasing the amount of acid made in the stomach.
Related Packages: 49483-0720-20Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Famotidine
Product Information
| NDC | 49483-0720 |
|---|---|
| Product ID | 49483-720_0b1af6f7-fecd-e0a5-e063-6394a90a7535 |
| Associated GPIs | |
| GCN Sequence Number | 011677 |
| GCN Sequence Number Description | famotidine TABLET 20 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 46430 |
| HICL Sequence Number | 004521 |
| HICL Sequence Number Description | FAMOTIDINE |
| Brand/Generic | Generic |
| Proprietary Name | Maximum Strength Acid Reducer |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Famotidine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | FAMOTIDINE |
| Labeler Name | TIME CAP LABORATORIES,INC |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA217543 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49483-0720-20 (49483072020)
| NDC Package Code | 49483-720-20 |
|---|---|
| Billing NDC | 49483072020 |
| Package | 200 TABLET in 1 BOTTLE (49483-720-20) |
| Marketing Start Date | 2023-06-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |